Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (TCTR20250910002) titled 'Efficacy and Safety of FLORANBIDIN in Patients with Chronic Insomnia: A Phase 2 Randomized, Double-Blind Clinical Trial' on Sept. 10.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: National Innovation Agency
Condition:
Chronic insomnia
Sleep disturbance
Sleep onset latency
Reduced sleep efficiency
Daytime sleepiness
Sleep fragmentation
Cannabidiol
CBD
Nano-emulsion
FLORANBIDIN
Chronic insomnia
Sleep quality
Sleep efficiency
Insomnia Severity Index
Belun Ring
Polysomnography
Non-pharmacological sleep aid
Piperine
Endocannabinoid system
Herbal supplement
Clinical trial
Cannabidiol
CBD
Na...